The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Consort Medical First Half Profit Falls Due To Cramlington Incident

Tue, 03rd Dec 2019 09:14

(Alliance News) - Consort Medical PLC on Tuesday said its interim profit was considerably smaller following an incident at its Aesica Cramlington manufacturing facility.

Consort's pretax profit for the six months ended October 31 was GBP1.2 million, far less than the GBP9.6 million profit posted the year before as revenue fell 4.3% to GBP146.0 million from GBP152.5 million.

This was primarily caused by the Cramlington incident, in which a small area of the Northumberland-based operating plant was damaged in what was described by Consort at the time as "the rapid thermal degradation of a chemical resulting in the expulsion of material and contamination of the facility".

This hurt the performance of its active pharmaceutical ingredients and finished dose manufacturing unit, Aesica, where revenue fell 11% to GBP81.1 million from GBP90.9 million.

Bespak, Consort's drug delivery devices unit, was unaffected, with revenue up 5.4% at GBP64.9 million versus GBP61.6 million the year prior.

On November 18, following the end of its first half, contract development and manufacturing pharmaceutical company Consort agreed to a GBP505 million bid from Swedish peer Recipharm AB. Recipharm will pay 1,010 pence in cash for each Consort share. The proposed deal implies an enterprise value of GBP627 million for Consort.

Given that Recipharm may reduce its acquisition consideration if any dividend or other distribution is made by the Hemel Hempstead-based company, Consort has opted not to declare an interim dividend.

Consort Chief Executive Jonathan Glenn said: "The board's expectations for the full year remain unchanged. We anticipate that the group's performance in the second half of the year will benefit from continued growth in Bespak, recommencing manufacture of the specific product involved in the Cramlington incident and a reduction in the backlog at Aesica.

"The group is subject to a recommended offer from Recipharm Holdings Ltd. The board remains confident of Consort's future prospects."

Shares in Consort were down 0.5% at 1,040.00 pence in London on Tuesday morning.

By Anna Farley; annafarley@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
29 Aug 2018 16:14

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 30 AugustFIH GroupCreightonsSophos GroupFriday 31 3 4 Investment 5

Read more
23 Aug 2018 17:32

Schroders Cuts Consort Medical Stake To Below 5% After Deal (ALLISS)

LONDON (Alliance News) - Consort Medical PLC said Thursday that Schroders PLC decreased its stake in the drug and delivery device manufacturer to below 5% after a transaction on holding after the

Read more
7 Aug 2018 14:50

Axxion Holds 6.0% Interest In Carclo After Transaction (ALLISS)

LONDON (Alliance News) - Plastic products firm Carclo PLC on Tuesday said Axxion SA now holds a 6.0% interest in the company after a transaction on Monday.Prior to that, Axxion's was on

Read more
7 Aug 2018 10:37

WINNERS & LOSERS SUMMARY: Domino's Pizza Slumps As Profit Falls

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------Standard Life

Read more
7 Aug 2018 09:57

Carclo Shares Drop 20% As Consort Medical Withdraws From Making Offer

LONDON (Alliance News) - Medical devices manufacturer Consort Medical PLC said Tuesday it does not intend to make an offer for industry peer Carclo PLC.Carclo shares were down 20% at 93.69

Read more
1 Aug 2018 12:20

James Cropper Appoints RHI Magnesita Non-Executive Hosty To Board

LONDON (Alliance News) - Paper products manufacturer James Cropper PLC said Wednesday that Andrew Hosty will join as non-executive director with immediate effect.Hosty has been an acting to

Read more
23 Jul 2018 10:23

Consort Medical Gets Extension To Make Firm Offer For Carclo

LONDON (Alliance News) - Plastic products maker Carclo PLC said Monday it has secured an extension to the deadline for Consort Medical PLC to make a firm offer for the company.The Panel on

Read more
2 Jul 2018 13:36

UPDATE: Carclo Rejects Takeover Approach By Consort Medical

LONDON (Alliance News) - Drug and medical device company Consort Medical PLC said Monday that plastics products maker Carclo PLC has rejected its non-binding acquisition proposal.Consort of

Read more
2 Jul 2018 10:58

WINNERS & LOSERS SUMMARY: Playtech Sinks On Asia Profit Warning

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------Micro Focus up

Read more
2 Jul 2018 09:57

Carclo Rejects Takeover Approach By Consort Medical

LONDON (Alliance News) - Drug and medical device company Consort Medical PLC said Monday that plastics products maker Carclo PLC has rejected its non-binding acquisition proposal.Consort of

Read more
14 Jun 2018 11:40

Consort Medical Annual Revenue Rises But Profit Slips On Restructuring

LONDON (Alliance News) - Consort Medical PLC on Thursday said it delivered a good growth across all of its divisions in its recently ended financial year, but profit fell on restructuring company

Read more
14 Jun 2018 09:33

BROKER RATINGS SUMMARY: UBS Cuts RELX; Barclays Cuts Pearson

LONDON (Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:----------FTSE 100----------UBS CUTS TO CUTS TO - TO

Read more
10 Feb 2017 16:12

UK Dividends Calendar - Next 7 Days

Read more
23 Jan 2017 15:23

Consort Medical pours more cash into Atlas Genetics

(ShareCast News) - Single-source drug and delivery device company Consort Medical announced on Monday that it has participated in a further equity raise by Atlas Genetics. The London-listed firm said that, following the successful CE-marking for the chlamydia trachomatis 'io' test cartridge, Atlas G

Read more
5 Jan 2017 13:29

UPDATE 2-BAT quits nicotine inhaler to focus on vaping

* BAT to transfer Voke rights back to Kind Consumer * Kind to search for new partners * BAT to concentrate efforts on vaping, tobacco-heating (Adds market data, background, byline) By Martinne Geller LONDON, Jan 5 (Reuters) - British American Tobacco (BAT) has quit plan

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.